| Shelli Ann Bulach, | |
|
1034 Sr 229 North, Batesville, IN 47006 | |
| (812) 933-6220 | |
| (812) 933-6255 |
| Full Name | Shelli Ann Bulach |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 1034 Sr 229 North, Batesville, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508404815 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 26021691A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Shelli Ann Bulach, 29112 Trackville Rd, Brookville, IN 47012-9546 Ph: (812) 576-0077 | Shelli Ann Bulach, 1034 Sr 229 North, Batesville, IN 47006 Ph: (812) 933-6220 |
News Archive
Bristol-Myers Squibb Canada is pleased to announce that Quebec has recognized the value of ABILIFY (aripiprazole) for the treatment of schizophrenia and related psychotic disorders in adults and has agreed to list ABILIFY as a reimbursed full benefit on the Quebec public drug plans as of October 14, 2010.
Global Health Technologies Coalition (GHTC) Communications Officer Kim Lufkin discusses USAID Administrator Rajiv Shah's second annual letter in this GHTC "Breakthroughs" blog post, writing, "Shah rightly emphasizes the role of science, technology, and innovation in meeting USAID's international health goals."
"In today's world, the majority of deaths go unregistered," but "the information that comes from accurate and complete records of deaths - who died, and why - constitutes a huge resource for evidence-based health planning and development," Peter Byass, a professor of global health at Umea University in Sweden and director of the Umea Centre for Global Health Research, writes in this post in the PLoS "Speaking of Medicine" blog.
Researchers at Harvard Medical School have identified a gene in Asian monkeys that may have evolved as a defense against lentiviruses, the group of viruses that includes HIV.
Endo Pharmaceuticals today announced actions designed to advance the company's leadership and growth in pain management, including an agreement to acquire all outstanding shares of Penwest Pharmaceuticals for $5.00 in cash per share, or an estimated enterprise value of approximately $144 million at the time of deal close. Penwest has been working with Endo since 1997 on the development and commercialization of OPANA® ER and receives a royalty stream on net sales of the product.
› Verified 1 days ago
Dr. Herbert Alfred Hunter, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 321 Mitchell Ave, Batesville, IN 47006 Phone: 812-933-5286 Fax: 812-933-5020 | |
Dr. Joseph T Dunn, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 907 State Road 229, Batesville, IN 47006 Phone: 812-934-5711 | |
Lori Walke, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 907 State Road 229, Batesville, IN 47006 Phone: 812-934-5711 | |
Mrs. Mary Angela Bradley, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 321 Mitchell Ave, Batesville, IN 47006 Phone: 812-934-6624 | |
Marisol Schutte, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1034 State Road 229, Batesville, IN 47006 Phone: 812-933-6220 | |
Rebecca Mallory, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1034 State Road 229, Batesville, IN 47006 Phone: 812-933-6220 Fax: 812-933-6255 |